[1] Singh K, Coburn LA, Asim M, et al. Ornithine decarboxylase in macrophages exacerbates colitis and promotes colitis-associated colon carcinogenesis by impairing M1 immune responses[J]. Cancer Res, 2018,78(15):4303-4315. DOI: 10.1158/0008-5472.CAN-18-0116.
[2] McNamara KM, Gobert AP, Wilson KT. The role of polyamines in gastric cancer[J]. Oncogene, 2021,40(26):4399-4412. DOI: 10.1038/s41388-021-01862-x.
[3] Correa P. Gastric cancer: overview[J]. Gastroenterol Clin North Am, 2013,42(2):211-217. DOI: 10.1016/j.gtc.2013.01.002.
[4] Liu Q, Tang J, Chen S, et al. Berberine for gastric cancer prevention and treatment: multi-step actions on the Correa's cascade underlie its therapeutic effects[J]. Pharmacol Res, 2022,184:106440. DOI: 10.1016/j.phrs.2022.106440.
[5] Correa P. Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention[J]. Cancer Res, 1992,52(24):6735-6740.
[6] Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021,71(3):209-249. DOI: 10.3322/caac.21660.
[7] Jaroenlapnopparat A, Bhatia K, Coban S. Inflammation and gastric cancer[J]. Diseases, 2022,10(3):35. DOI: 10.3390/diseases10030035.
[8] Zhang M, Li X, Zhang Q, et al. Roles of macrophages on ulcerative colitis and colitis-associated colorectal cancer[J]. Front Immunol, 2023,14:1103617. DOI: 10.3389/fimmu.2023.1103617.
[9] Pereira-Marques J, Ferreira RM, Pinto-Ribeiro I, et al. Helicobacter pylori Infection, the gastric microbiome and gastric cancer[J]. Adv Exp Med Biol, 2019,1149:195-210. DOI: 10.1007/5584_2019_366.
[10] Romero-Gallo J, Harris EJ, Krishna U, et al. Effect of Helicobacter pylori eradication on gastric carcinogenesis[J]. Lab Invest, 2008,88(3):328-336. DOI: 10.1038/labinvest.3700719.
[11] Vitale I, Manic G, Coussens LM, et al. Macrophages and metabolism in the tumor microenvironment[J]. Cell Metab, 2019,30(1):36-50. DOI: 10.1016/j.cmet.2019.06.001.
[12] Obeid E, Nanda R, Fu YX, et al. The role of tumor-associated macrophages in breast cancer progression (review)[J]. Int J Oncol, 2013,43(1):5-12. DOI: 10.3892/ijo.2013.1938.
[13] Rahal OM, Wolfe AR, Mandal PK, et al. Blocking interleukin (IL)4- and IL13-mediated phosphorylation of STAT6 (Tyr641) decreases M2 polarization of macrophages and protects against macrophage-mediated radioresistance of inflammatory breast cancer[J]. Int J Radiat Oncol Biol Phys, 2018,100(4):1034-1043. DOI: 10.1016/j.ijrobp.2017.11.043.
[14] Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas[J]. J Clin Invest, 2012,122(3):787-795. DOI: 10.1172/JCI59643.
[15] Han J, Dong L, Wu M, et al. Dynamic polarization of tumor-associated macrophages and their interaction with intratumoral T cells in an inflamed tumor microenvironment: from mechanistic insights to therapeutic opportunities[J]. Front Immunol, 2023,14:1160340. DOI: 10.3389/fimmu.2023.1160340.
[16] Gao J, Liang Y, Wang L. Shaping polarization of tumor-associated macrophages in cancer immunotherapy[J]. Front Immunol, 2022,13:888713. DOI: 10.3389/fimmu.2022.888713.
[17] Zhang G, Gao Z, Guo X, et al. CAP2 promotes gastric cancer metastasis by mediating the interaction between tumor cells and tumor-associated macrophages[J]. J Clin Invest, 2023,133(21):e166224. DOI: 10.1172/JCI166224.
[18] Guo J, Li Z, Ma Q, et al. Dextran sulfate inhibits angiogenesis and invasion of gastric cancer by interfering with M2-type macrophages polarization[J]. Curr Cancer Drug Targets, 2022,22(11):904-918. DOI: 10.2174/1568009622666220705095403.
[19] Najafi M, Hashemi Goradel N, Farhood B, et al. Macrophage polarity in cancer: a review[J]. J Cell Biochem, 2019,120(3):2756-2765. DOI: 10.1002/jcb.27646.
[20] Pegg AE. Mammalian polyamine metabolism and function[J]. IUBMB Life, 2009,61(9):880-894. DOI: 10.1002/iub.230.
[21] Ramos-Molina B, Queipo-Ortuño MI, Lambertos A, et al. Dietary and gut microbiota polyamines in obesity- and age-related diseases[J]. Front Nutr, 2019,6:24. DOI 10.3389/fnut.2019.00024.
[22] Casero RA Jr, Murray Stewart T, Pegg AE. Polyamine metabolism and cancer: treatments, challenges and opportunities[J]. Nat Rev Cancer, 2018,18(11):681-695. DOI: 10.1038/s41568-018-0050-3.
[23] Brzozowski T, Konturek PC, Konturek SJ, et al. Involvement of ornithine decarboxylase and polyamines in epidermal growth factor-induced recovery of gastric mucosa from gastric lesions provoked by stress[J]. Regul Pept, 1998,74(2-3):73-84. DOI: 10.1016/s0167-0115(98)00020-2.
[24] Miao XP, Li JS, Li HY, et al. Expression of ornithine decarboxylase in precancerous and cancerous gastric lesions[J]. World J Gastroenterol, 2007,13(20):2867-2871. DOI: 10.3748/wjg.v13.i20.2867.
[25] Lundell L, Rosengren E. Polyamine levels in human gastric carcinoma[J]. Scand J Gastroenterol, 1986,21(7):829-832. DOI: 10.3109/00365528609011126.
[26] Brooks WH. Increased polyamines alter chromatin and stabilize autoantigens in autoimmune diseases[J]. Front Immunol, 2013,4:91. DOI: 10.3389/fimmu.2013.00091.
[27] Latour YL, Gobert AP, Wilson KT. The role of polyamines in the regulation of macrophage polarization and function[J]. Amino Acids, 2020,52(2):151-160. DOI: 10.1007/s00726-019-02719-0.
[28] Chia TY, Zolp A, Miska J. Polyamine immunometabolism: central regulators of inflammation, cancer and autoimmunity[J]. Cells, 2022,11(5):896. DOI: 10.3390/cells11050896.
[29] Hardbower DM, Asim M, Luis PB, et al. Ornithine decarboxylase regulates M1 macrophage activation and mucosal inflammation via histone modifications. Proc Natl Acad Sci U S A, 2017,114(5):E751-E760. DOI: 10.1073/pnas.1614958114.
[30] Srivastava S, Bhowmick K, Chatterjee S, et al. Histone H3K9 acetylation level modulates gene expression and may affect parasite growth in human malaria parasite Plasmodium falciparum[J]. FEBS J, 2014,281(23):5265-5278. DOI: 10.1111/febs.13067.
[31] Miao H, Ou J, Peng Y, et al. Macrophage ABHD5 promotes colorectal cancer growth by suppressing spermidine production by SRM[J]. Nat Commun, 2016,7:11716. DOI: 10.1038/ncomms11716.
[32] Wang Z, Han W, Xue F, et al. Nationwide gastric cancer prevention in China, 2021-2035: a decision analysis on effect, affordability and cost-effectiveness optimisation[J]. Gut, 2022,71(12):2391-2400. DOI: 10.1136/gutjnl-2021-325948.
[33] Collatuzzo G, Pelucchi C, Negri E, et al. Exploring the interactions between helicobacter pylori (Hp) infection and other risk factors of gastric cancer: a pooled analysis in the stomach cancer pooling (StoP) project[J]. Int J Cancer, 2021,149(6):1228-1238. DOI: 10.1002/ijc.33678.
|